International Stem Cell (ISCO) Total Current Liabilities (2010 - 2026)
International Stem Cell (ISCO) posted Total Current Liabilities of $4.98 million for Q2 2026, up 0.9% from $4.94 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Total Current Liabilities came in at $4.58 million, down 2.3% from FY2024.
- Annual Total Current Liabilities shows a five-year compound annual growth rate of 25.3% (FY2020 to FY2025).
- In prior years, International Stem Cell's Total Current Liabilities was $4.69 million in FY2024 (-3.0%), $4.83 million in FY2023 (+4.3%), $4.64 million in FY2022 (+8.2%) and $4.28 million in FY2021 (+188.9%).
- The Q2 2026 figure stands as the highest quarterly Total Current Liabilities since Q1 2025.
- On a year-over-year basis, Total Current Liabilities increased in three of the last seven quarters, with an average decline of 0.5%.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2021, with growth of 188.9%; the weakest was Q4 2024, with a decline of 3.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 32.65 Bn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn | 4.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.98 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 5.02 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | 4.64 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Jun 30, 2022 | 4.69 Mn |
| Mar 31, 2022 | 4.81 Mn |
| Dec 31, 2021 | 4.28 Mn |
| Sep 30, 2021 | 4.35 Mn |
| Jun 30, 2021 | 4.43 Mn |
API Access
International Stem Cell Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();